Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Haploidentical, Donor-Derived B Lymphocyte Infusions in Patients With Amyotrophic Lateral Sclerosis

NCT07838389 is registered in ClinicalTrials.gov with Mark Poznansky as lead sponsor.

NCT NCT07838389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07838389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Haploidentical, Donor-Derived B Lymphocyte Infusions in Patients With Amyotrophic Lateral Sclerosis
Lead sponsor
Mark Poznansky
Phase
Phase 1
Overall status
Not yet recruiting
Start date
September 30, 2027
Completion date
January 31, 2030
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

als - amyotrophic lateral sclerosis